Share on StockTwits
 

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 16,700 shares of the stock in a transaction dated Tuesday, January 21st. The shares were purchased at an average price of $8.82 per share, for a total transaction of $147,294.00. Following the transaction, the chief executive officer now directly owns 1,987,500 shares of the company’s stock, valued at approximately $17,529,750. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

A number of research firms have recently commented on OPK. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.

OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.